Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
2.
J Laryngol Otol ; 137(12): 1326-1333, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36093951

ABSTRACT

BACKGROUND: Totally endoscopic ear surgery is a novel method of conducting otological surgery. Hierarchical task analysis and the systematic human error reduction and prediction approach ('SHERPA') are valuable tools that can effectively deconstruct the technical and non-technical skills required to successfully complete a surgical procedure. METHODS: Twenty-five endoscopic tragal cartilage tympanoplasties were observed, to identify the tasks and subtasks required for completion of totally endoscopic tragal cartilage tympanoplasty. The systematic human error reduction and prediction approach was used to identify the potential risks and methods, to reduce or remediate these risks. RESULTS: A hierarchical task analysis was performed, identifying 8 tasks and 50 subtasks for a safe approach to completing totally endoscopic tragal cartilage tympanoplasty. A risk score for each subtask was calculated to produce a systematic human error reduction and prediction approach and to highlight potential errors. CONCLUSION: This hierarchical task analysis allowed for quick reference to a correct method of endoscopic tympanoplasty. The systematic human error reduction and prediction approach was employed to reduce the risks associated with undergoing endoscopic tympanoplasty, to improve patient safety.


Subject(s)
Cartilage , Tympanoplasty , Humans , Tympanoplasty/methods , Treatment Outcome , Retrospective Studies , Endoscopy/methods
4.
J Laryngol Otol ; : 1-7, 2020 Sep 30.
Article in English | MEDLINE | ID: mdl-32993840

ABSTRACT

OBJECTIVES: Children with autism spectrum disorder face a broad range of communication and sensory challenges. Many of these children also have chronic ENT issues. This study aims to better understand these challenges and improve our services for children with autism spectrum disorder. METHODS: Questionnaires and semi-structured interviews were carried out with parents of children with autism spectrum disorder. RESULTS: Thirty-four individuals participated, comprising 9 caregivers and 25 staff members. All parents recognised their critical roles in understanding their children's special needs and sensitivities. Parents and staff stressed the importance of a partnership role that inquired about unique needs, leading to environmental modifications for individual children. CONCLUSION: The importance of listening to and involving caregivers is a fundamental tenet; parents must be recognised as the experts. Uncertainty must be kept to a minimum, with clear communication in a structured, low-arousal environment for these children. We have listened to parents and staff, and developed a social story.

5.
QJM ; 113(1): 17-19, 2020 Jan 01.
Article in English | MEDLINE | ID: mdl-31407005

ABSTRACT

BACKGROUND: Sarcoidosis is occasionally seen in association with malignancy, both at the time of cancer diagnosis or during follow up. AIM: The purpose of this study is to identify patients with paraneoplastic sarcoid, their associated malignancies and disease characteristics. METHODS: We identified 289 patients diagnosed histologically with sarcoidosis over a 6-year period in one centre, from 2010 to 2016. Fifty of these patients had a prior or concomitant diagnosis of cancer. RESULTS: 17.3% of sarcoid cases had an associated malignancy. The most common malignancies were Gastrointestinal (20%), Haematological (18%), Lung (12%), Gynaecological (12%) and Head and Neck cancer (12%). 74% of sarcoid cases had pulmonary disease with sarcoid diagnostic tissue obtained most frequently via endobronchial ultrasound fine needle aspiration (68%). Most sarcoid cases (66%) were diagnosed within the first year of their malignancy diagnosis. DISCUSSION: Careful consideration needs to be given to the possibility that potential cancer recurrences suspected on imaging studies may indeed be sarcoid reactions.


Subject(s)
Neoplasms/diagnosis , Sarcoidosis/diagnosis , Adult , Aged , Aged, 80 and over , Biopsy, Fine-Needle , Endosonography , Female , Humans , Ireland , Male , Middle Aged , Neoplasm Recurrence, Local , Neoplasms/epidemiology , Neoplasms/pathology , Retrospective Studies , Risk Assessment , Risk Factors , Sarcoidosis/epidemiology , Sarcoidosis/pathology , Time Factors , Treatment Outcome
7.
Lupus ; 24(1): 66-73, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25288030

ABSTRACT

OBJECTIVES: The objectives of this paper are to prospectively determine the incidence of paediatric systemic lupus erythematosus (pSLE) in Australia as well as describe the demographics, clinical presentation and one-year outcome. STUDY DESIGN: Newly diagnosed cases of pSLE were ascertained prospectively from October 2009 to October 2011 through the Australian Paediatric Surveillance Unit (a national monthly surveillance scheme for notification of childhood rare diseases) as well as national subspecialty groups. Questionnaires were sent to notifying physicians at presentation and at one year. RESULTS: The annual incidence rate was 0.32 per 10(5) children aged less than 16 years. The incidence was significantly higher in children of Asian or Australian Aboriginal and Torres Strait Islander parents. Approximately one-third of children underwent a renal biopsy at presentation and 7% required dialysis initially although only one child had end-stage kidney disease (ESKD) at one-year follow-up. CONCLUSION: The incidence of pSLE in Australia is comparable to that worldwide with a significantly higher incidence seen in children of Asian and Australian Aboriginal and Torres Strait Islander backgrounds. Renal involvement is common but progression to ESKD, at least in the short term, is rare.


Subject(s)
Asian People/statistics & numerical data , Lupus Erythematosus, Systemic/epidemiology , Native Hawaiian or Other Pacific Islander/statistics & numerical data , Adolescent , Age of Onset , Antibodies, Antinuclear/blood , Australia/epidemiology , Child , Child, Preschool , Disease Progression , Female , Follow-Up Studies , Humans , Incidence , Lupus Erythematosus, Systemic/drug therapy , Lupus Erythematosus, Systemic/ethnology , Lupus Nephritis/epidemiology , Lupus Nephritis/pathology , Lupus Nephritis/therapy , Male , Prospective Studies , Proteinuria/etiology , Rheumatic Fever/etiology
8.
Transpl Infect Dis ; 16(4): 672-5, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24995624

ABSTRACT

We report a case of Mycobacterium kansasii presenting as an obstructing endobronchial mass in a patient post stem cell transplant. The patient had a complete clinical, microbiological, and radiological response to anti-tuberculous treatment. To our knowledge, this is the first case of M. kansasii presenting post transplant with an obstructing lung mass simulating relapse or post-transplant lymphoma.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium kansasii/isolation & purification , Stem Cell Transplantation/adverse effects , Adult , Clarithromycin/administration & dosage , Clarithromycin/therapeutic use , Drug Resistance, Bacterial , Ethambutol/administration & dosage , Ethambutol/therapeutic use , Female , Humans , Isoniazid/administration & dosage , Isoniazid/therapeutic use , Mycobacterium kansasii/drug effects , Rifampin/administration & dosage , Rifampin/therapeutic use
10.
J Inherit Metab Dis ; 31 Suppl 2: S271-3, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18855117

ABSTRACT

Two neonates were identified at age 48 h by expanded newborn screening, with abnormal methionine and tyrosine concentrations, which were confirmed on repeat samples. Evidence of previously unsuspected liver disease was found at recall, and there was radiological and biochemical evidence of severe liver disease with hepatic synthetic failure. After inborn errors of metabolism (IEMs) were excluded, both were considered to have neonatal haemochromatosis, on the basis of raised ferritin, iron saturation, and very high α-fetoprotein and confirmed by a mildly hyperferritinaemic sibling in the first case, and raised ferritin and iron saturation in the second. However, it was not feasible to obtain tissue confirmation as the requirement for early therapy precluded biopsy. The babies were treated with antioxidants and iron-chelating agents, and the coagulopathy and hypoalbuminaemia were corrected. Both made a complete recovery and remain well after follow-up. Newborn screening programmes could consider advising clinicians, when tyrosine and methionine values are elevated, that once IEMs are excluded liver disease from other causes must be sought. Neonatal haemochromatosis is an example of one such disease that is potentially treatable.


Subject(s)
Hemochromatosis/diagnosis , Liver/metabolism , Methionine/blood , Neonatal Screening , Tyrosine/blood , Amino Acid Metabolism, Inborn Errors/diagnosis , Antioxidants/therapeutic use , Biomarkers/blood , Blood Coagulation Disorders/blood , Blood Coagulation Disorders/diagnosis , Diagnosis, Differential , Ferritins/blood , Hemochromatosis/blood , Hemochromatosis/drug therapy , Humans , Hypoalbuminemia/blood , Hypoalbuminemia/diagnosis , Infant, Newborn , Iron/blood , Iron Chelating Agents/therapeutic use , Male , Neonatal Screening/methods , Predictive Value of Tests , Tandem Mass Spectrometry , Treatment Outcome , alpha-Fetoproteins/analysis
11.
Immunol Res ; 31(2): 75-89, 2005.
Article in English | MEDLINE | ID: mdl-15778507

ABSTRACT

Antimicrobial peptides form an important component of the innate immune system. The cathelicidin family, a key member of the antimicrobial peptide defenses, has been highly conserved throughout evolution. Though widespread in mammals, there is currently only one identified human example, hCAP-18/LL-37. The cathelicidins have been found to have multiple functions, in addition to their known antimicrobial and lipopolysaccharide-neutralizing effects. As a result, they profoundly affect both innate and adaptive immunity. Currently, antimicrobial peptides are being evaluated as therapeutic drugs in disease states as diverse as oral mucositis, cystic fibrosis, and septic shock. One such peptide, the cathelicidin hCAP-18/LL-37, is reviewed in detail in the context of its role in lung physiology and defense.


Subject(s)
Adjuvants, Immunologic/physiology , Antimicrobial Cationic Peptides/physiology , Immunity, Innate/immunology , Lung Diseases/immunology , Lung Diseases/prevention & control , Adjuvants, Immunologic/biosynthesis , Adjuvants, Immunologic/genetics , Antimicrobial Cationic Peptides/biosynthesis , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/therapeutic use , Humans , Lung Diseases/microbiology , Lung Diseases/virology , Cathelicidins
12.
Chest ; 119(1): 196-203, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11157604

ABSTRACT

OBJECTIVES: To determine if the increased susceptibility to bacterial infection in asymptomatic HIV-infected patients is associated with decreased total IgG or IgG2 levels in lung epithelial lining fluid. BACKGROUND: A decrease in lung IgG levels or subtypes has been proposed as contributing to the increased risk of bacterial lung infections in HIV-infected patients. Previous studies measuring lung lavage IgG concentrations have been inconsistent. METHODS: Twenty-three HIV patients and 25 control subjects underwent BAL. Both patient groups were of similar age, and had similar pulmonary function studies and body mass index. Smokers were equally represented in both groups, and the majority of subjects in both groups were male. Total IgG and IgG2 levels in lavage fluid were assayed in both cohorts and compared using a two-tailed Student's t test. RESULTS: The lung lining fluid IgG level in HIV-infected patients was 0.19 +/- 0.13 microg/microg of protein (mean +/- SD) vs 0.11 +/- 0.09 microg/microg of protein in control subjects (p < 0.05). The IgG(2) level in HIV patients was 0.034 +/- 0.038 microg/microg of protein and 0.014 +/- 0.01 microg/microg of protein in control subjects (p = 0.054). Lavage IgG levels reflected serum IgG values (correlation coefficient, 0.56; p < 0.001) but did not correlate with lung immunoglobulin-producing cells. CONCLUSIONS: The increased susceptibility to bacterial pneumonia in asymptomatic HIV-infected individuals is neither explained by depressed total IgG levels nor a deficiency in IgG(2) levels in the lungs. The strong correlation between serum and lavage IgG levels suggests that lavage IgG derives from serum.


Subject(s)
AIDS-Related Opportunistic Infections/immunology , Bronchoalveolar Lavage Fluid/immunology , HIV Infections/immunology , Immunoglobulin G/blood , Pneumonia, Bacterial/immunology , AIDS-Related Opportunistic Infections/diagnosis , Adult , Cohort Studies , Female , HIV Infections/diagnosis , Humans , Lymphocyte Count , Male , Middle Aged , Pneumonia, Bacterial/diagnosis , Risk Factors , T-Lymphocyte Subsets/immunology
13.
Am J Respir Crit Care Med ; 161(5): 1705-12, 2000 May.
Article in English | MEDLINE | ID: mdl-10806178

ABSTRACT

Despite recent investigations, the mechanisms responsible for intestinal epithelial injury during endotoxemia remain unclear. The present study tests the hypothesis that epithelial necrosis and/or apoptosis correlate with nitric oxide (NO) dysregulation in a nonischemic model of sepsis-induced ileal injury. To test this hypothesis, a well-established in situ, autoperfused, feline ileal preparation was employed. After endotoxin (lipopolysaccharide [LPS], 3 mg/ kg, intravenously; n = 9) or vehicle (control; n = 5) treatment, ileal segments were obtained at baseline, 2 and 4 h for simultaneous evaluations of cellular and mitochondrial ultrastructure, immunoprevalence of inducible nitric oxide synthase (iNOS) and 3-nitrotyrosine (a stable biomarker of peroxynitrite), and histochemical evidence of apoptosis. Epithelial necrosis was prominent by 2 h post-LPS, despite unaltered global ileal tissue oxygen content, blood volume, and blood flow. Significant evidence of apoptosis and increases in the immunoprevalence of iNOS and 3-nitrotyrosine were not evident until 4 h post-LPS. These results suggest that the early ileal mucosal necrosis may be due to LPS-induced activation of inflammatory pathways and/or microcirculatory disturbances, whereas NO dysregulation may participate in later events, including protein nitration and epithelial apoptosis.


Subject(s)
Ileum/pathology , Intestinal Mucosa/pathology , Nitric Oxide/physiology , Sepsis/pathology , Animals , Apoptosis , Cats , Ileum/metabolism , Ileum/ultrastructure , Immunohistochemistry , Intestinal Mucosa/metabolism , Lipopolysaccharides , Male , Mitochondria/ultrastructure , Multiple Organ Failure/etiology , Multiple Organ Failure/pathology , Multiple Organ Failure/physiopathology , Necrosis , Nitric Oxide Synthase/analysis , Nitric Oxide Synthase Type II , Oxygen Consumption , Sepsis/complications , Sepsis/metabolism , Tyrosine/analogs & derivatives , Tyrosine/analysis
14.
South Med J ; 93(12): 1212-6, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11142460

ABSTRACT

Although exceedingly rare, fulminant hepatic failure (FHF) in immunocompetent patients can develop with primary or recurrent infection due to herpes simplex virus (HSV). The diagnosis is frequently obscured by the absence of mucocutaneous involvement. Elevated transaminase values with leukopenia and a relatively low bilirubin level may provide clues to the diagnosis. We describe an immunocompetent woman who died of FHF before a definitive diagnosis of HSV type 2 hepatitis was established. Herpes simplex virus hepatitis is one of the few causes of FHF for which potentially effective therapy is available. Thus, early diagnosis is paramount and usually requires liver biopsy. Recent studies suggest that transjugular liver biopsy is safe and effective in establishing the cause of FHF. Since the diagnosis and management of FHF are frequently influenced by the results of transjugular liver biopsy, it may become a standard diagnostic tool for managing FHF in centers where such expertise exists.


Subject(s)
Herpes Genitalis/complications , Liver Failure/virology , Acyclovir/therapeutic use , Antiviral Agents/therapeutic use , Fatal Outcome , Female , Humans , Immunocompetence , Liver/pathology , Liver Failure/diagnosis , Liver Failure/drug therapy , Middle Aged
15.
J Immunol ; 163(4): 1755-62, 1999 Aug 15.
Article in English | MEDLINE | ID: mdl-10438906

ABSTRACT

Apoptosis is an important mechanism for regulating the numbers of monocytes and macrophages. Caspases (cysteine-aspartate-specific proteases) are key molecules in apoptosis and require proteolytic removal of prodomains for activity. Caspase-1 and caspase-3 have both been connected to apoptosis in other model systems. The present study attempted to delineate what role these caspases play in spontaneous monocyte apoptosis. In serum-free conditions, monocytes showed a commitment to apoptosis as early as 4 h in culture, as evidenced by caspase-3-like activity. Apoptosis, as defined by oligonucleosomal DNA fragmentation, was prevented by a generalized caspase inhibitor, z-VAD-FMK, and the more specific caspase inhibitor, z-DEVD-FMK. The caspase activity was specifically attributable to caspase-3 by the identification of cleavage of procaspase-3 to active forms by immunoblots and by cleavage of the fluorogenic substrate DEVD-AFC. In contrast, a caspase-1 family inhibitor, YVAD-CMK, did not protect monocytes from apoptosis, and the fluorogenic substrate YVAD-AFC failed to show an increase in activity in apoptotic monocytes. When cultured with LPS (1 microgram/ml), monocyte apoptosis was prevented, as was the activation of caspase-3. Unexpectedly, LPS did not change baseline caspase-1 activity. These findings link spontaneous monocyte apoptosis to the proteolytic activation of caspase-3.


Subject(s)
Apoptosis/immunology , Caspase 1/physiology , Caspases/physiology , Lipopolysaccharides/pharmacology , Monocytes/cytology , Monocytes/enzymology , Caspase 3 , Caspase Inhibitors , Caspases/blood , Cell Survival/immunology , Enzyme Activation/immunology , Humans , Interleukin-1/metabolism , Monocytes/immunology , Protein Precursors/metabolism , Signal Transduction/immunology
18.
Fire J ; 83(4): 52-5, 57, 59-62 passim, 1989.
Article in English | MEDLINE | ID: mdl-10293581
SELECTION OF CITATIONS
SEARCH DETAIL
...